ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold

Area of Science:

• Cell Biology
• Molecular Oncology
• Signal Transduction

Background:

• Ras proteins are key regulators of cell signaling, and their aberrant activation drives tumor formation.
• Ras signaling relies on its organization into nanoscale signaling complexes (nanoclusters) at the plasma membrane.
• ASPP2 (Arfaptin-2 binding protein 2) has been implicated in tumor suppression, but its role in Ras nanoclustering is unclear.

Purpose of the Study:

• To investigate the role of ASPP2 in Ras nanoclustering.
• To determine how ASPP2 influences Ras signaling pathways and cellular outcomes.
• To elucidate the competitive interaction between ASPP2 and the nanocluster scaffold Gal-1.

Main Methods:

• Analysis of Ras nanoclustering using super-resolution microscopy.
• Structure-function studies of ASPP2 using truncation mutants.
• Assessment of downstream signaling pathways (ERK, AKT) and cellular phenotypes (colony formation, senescence, mammosphere formation).

Main Results:

• ASPP2 enhances the nanoscale clustering of all oncogenic Ras isoforms (H-ras, K-ras, N-ras).
• ASPP2's scaffolding activity for nanoclustering resides in its α-helical domain.
• ASPP2 induces senescence and suppresses cancer stem cell formation, opposing the growth-promoting effects of Gal-1.

Conclusions:

• ASPP2 acts as a scaffold that promotes Ras nanoclustering, leading to tumor-suppressive effects.
• ASPP2 and Gal-1 compete for active Ras in nanoclusters, with ASPP2 dominating the biological outcome.
• Ras nanoclusters integrate signals that determine tumor fate, with ASPP2 promoting senescence and suppressing stemness.